Patent Yard Sign in
Expired Canadian patentCanada

Pyrazolo and pyrrolopyridines

CA 2192820 C · Owner: Chen, Yuhpyng L. · Inventors: Chen, Yuhpyng L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates to compounds of formula (I) wherein A is N or -CT6; B , is -NR1R2, -CR1R2R11 - C(=CR2R12)R1, -NHCHR1R2, - OCHR1R2, -SCHR1R2 -, CHR2OR12, -CHR2SR12, -C(S)R1 or -C(O)R1. The compounds show corticotropinreleasing factor (CRF) antagonist activity. CFR antagonists are believed to be effective in the treatment of a wide range of stress-related illnesses such , as depression, anxiety, headache irritable bowel syndrome, inflammatory diseases, immune suppressin, Alzheimer's disease gastrointestinal diseases, anorexia nervosa hemmorrhagic stress, drug and alcohol withdrawal symptoms drug addiction and infertility.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 18, 1995 and granted November 28, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 18, 2015.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 18, 2017.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 18, 1995
GrantedNovember 28, 2000
Term endedMay 18, 2015
Patent numberCA 2192820 C
Classification (IPC)C07D471/04 +2 more

Timeline

Timeline From CIPO dates

1996199820002002200420062008201020122014Application filedMay 18, 1995Patent grantedNov 28, 2000Term endedMay 18, 2015

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.